Open-Label Extension Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1) Open-Label Extension Study of Ubenimexin Patients With Pulmonary Arterial Hypertension (WHO Group 1) ...
A Phase 2, Open-Label, Extension Study to Evaluate the Long-Term Safety and Efficacy of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1) A Phase 2, Open-Label, Extension Study to Evaluate the Long-Term Safety and Efficacy of Ubenimexin P ...
A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
A Phase 2, Randomized, Double-BLInd, Placebo- Controlled Study of UBEnimex in Patients With Pulmonary ARTerial HYpertension (WHO Group 1) (LIBERTY) A Phase 2, Randomized, Double-BLInd, Placebo- Controlled Study of UBEnimexin Patients With Pulmonary ...